Leggett & Platt (LEG) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The 2025 annual meeting will be held virtually on May 7, 2025, with advance registration required for participation and voting rights based on share ownership as of March 5, 2025.
Four main proposals will be presented: election of eight directors, ratification of PwC as auditor, advisory vote on executive compensation, and approval of the amended Flexible Stock Plan.
The Board recommends voting in favor of all proposals, and proxy materials are available online for shareholder review.
Voting matters and shareholder proposals
Shareholders will vote on electing eight directors, ratifying PwC as auditor, approving executive compensation, and amending the Flexible Stock Plan.
Shareholders can submit director nominations and proposals for future meetings, with specific deadlines and requirements outlined in the bylaws.
Proxy access allows groups holding at least 3% of shares for three years to nominate up to 20% of the Board.
Board of directors and corporate governance
The Board consists of a mix of experienced and new independent directors, with a focus on diversity—five of seven independent nominees are diverse, including three women and three racial/ethnic minorities.
Board committees (Audit, HRC, NGS) are composed entirely of independent directors and meet regularly, with all directors attending at least 75% of meetings.
The Board has adopted Corporate Governance Guidelines, a Code of Business Conduct and Ethics, and a Financial Code of Ethics.
The Board leadership structure includes a combined Chairman/CEO and an independent Lead Director.
Latest events from Leggett & Platt
- Disciplined restructuring and innovation drive margin improvement and cash flow amid market headwinds.LEG
Investor presentation10 Mar 2026 - 2026 outlook: flat-to-down sales, margin gains, and focus on debt reduction amid weak demand.LEG
Q4 202512 Feb 2026 - Q2 loss driven by $675M impairment, lower sales, and restructuring; dividend cut for deleveraging.LEG
Q2 20242 Feb 2026 - Sales and earnings fell, guidance cut, and restructuring, impairment, and deleveraging continue.LEG
Q3 202418 Jan 2026 - Adjusted EPS up to $0.24 despite 7% sales drop; 2025 outlook and deleveraging focus maintained.LEG
Q1 202527 Dec 2025 - Restructuring and cost actions drive margin gains amid weak demand and a cautious 2025 outlook.LEG
Q4 202423 Dec 2025 - Virtual annual meeting to vote on directors, auditor, executive pay, and stock plan amendment.LEG
Proxy Filing1 Dec 2025 - Virtual annual meeting to vote on directors, auditor, compensation, and stock plan.LEG
Proxy Filing1 Dec 2025 - Sales fell 6% but margins and adjusted EPS improved, with guidance and balance sheet strengthened.LEG
Q2 202516 Nov 2025